iStopMM

En janvier 2016, le projet iStopMM a lancé une opération de dépistage chez tous les adultes de plus de 40 ans en Islande, dans le but de prévenir le myélome avant qu’il ne se développe.

Un document décrivant les méthodes utilisées dans l’étude iStopMM a été publié

Obtenez davantage d'informations sur la Gammapathie Monoclonale de Signification Indéterminée (MGUS)

Obtenez davantage d'informations sur le MGUS et téléchargez les derniers développements en matière de surveillance du MGUS par le Dr Ola Landgren et al.

    <ol> <li>Kyle, R. A. et al. <span style="color: #222222;">Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. <em>Leukemia</em> 24, 1121&ndash;1127 (2010).</span></li> <li>Sigurdardottir, E. E. et al. <span style="color: #222222; background: white;">The role of diagnosis and clinical follow-up of monoclonal gammopathy of undetermined significance on survival in multiple myeloma.&nbsp;<em>JAMA Oncol.</em>&nbsp;1, 168&ndash;174 (2015).</span></li> <li>Go, R. S., Gundrum, J. D. &amp; Neuner, J. M. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-medicare population analysis.&nbsp;<em style="color: #222222;">Clin. Lymphoma Myeloma Leuk.</em><span style="background-color: white; color: #222222;">&nbsp;15, 117&ndash;186 (2015).</span></li> <li>Goyal, G. et al. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma.&nbsp;<em style="color: #222222;">Leukemia</em><span style="background-color: white; color: #222222;">&nbsp;33, 1273&ndash;1277 (2019).</span></li> <li>R&ouml;gnvaldsson, S., Love, T.J., Thorsteinsdottir, S.&nbsp;<em style="color: #222222;">et al.</em><span style="background-color: white; color: #222222;">&nbsp;Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.&nbsp;</span><em style="color: #222222;">Blood Cancer J.</em><span style="background-color: white; color: #222222;">&nbsp;11</span><strong style="color: #222222;">,&nbsp;</strong><span style="background-color: white; color: #222222;">94 (2021).</span></li> </ol>